Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Breast Neoplasms 1223Neoplasms 1028Carcinoma, Non-Small-Cell Lung 747Prostatic Neoplasms 693Colorectal Neoplasms 591Lung Neoplasms 576Leukemia, Myeloid, Acute 396Pancreatic Neoplasms 395Neoplasm Metastasis 389Ovarian Neoplasms 369Multiple Myeloma 369Stomach Neoplasms 318Carcinoma, Hepatocellular 303Melanoma 283Brain Neoplasms 281Recurrence 274Squamous Cell Carcinoma of Head and Neck 266Head and Neck Neoplasms 239Glioblastoma 235Endometrial Neoplasms 232Triple Negative Breast Neoplasms 230Lymphoma 223Precursor Cell Lymphoblastic Leukemia-Lymphoma 222Uterine Cervical Neoplasms 221Sarcoma 202Hematologic Neoplasms 202Urinary Bladder Neoplasms 198Esophageal Neoplasms 190Carcinoma, Renal Cell 188Lymphoma, Non-Hodgkin 176

Interventions

mirdametinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Ganglioglioma × 1 year × Clear all
NCT04065776 2026-04-24

Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

St. Jude Children's Research Hospital

Phase NA Recruiting
74 enrolled
CNS

Astrocytoma, Glioma, Ganglioglioma

NCT04923126 2026-02-04

SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
132 enrolled
CNS

Astrocytoma, Ganglioneuroma, Oligodendroglioma, Neoplasms, Neuroepithelial, Ganglioglioma, Neurocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡